PMID- 17029981 OWN - NLM STAT- MEDLINE DCOM- 20070302 LR - 20220310 IS - 1044-7431 (Print) IS - 1095-9327 (Electronic) IS - 1044-7431 (Linking) VI - 33 IP - 4 DP - 2006 Dec TI - BDNF up-regulates alpha7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons. PG - 381-8 AB - In the hippocampus, brain-derived neurotrophic factor (BDNF) regulates a number of synaptic components. Among these are nicotinic acetylcholine receptors containing alpha7 subunits (alpha7-nAChRs), which are interesting because of their relative abundance in the hippocampus and their high relative calcium permeability. We show here that BDNF elevates surface and intracellular pools of alpha7-nAChRs on cultured hippocampal neurons and that glutamatergic activity is both necessary and sufficient for the effect. Blocking transmission through NMDA receptors with APV blocked the BDNF effect; increasing spontaneous excitatory activity with the GABA(A) receptor antagonist bicuculline replicated the BDNF effect. BDNF antibodies blocked the BDNF-mediated increase but not the bicuculline one, consistent with enhanced glutamatergic activity acting downstream from BDNF. Increased alpha7-nAChR clusters were most prominent on interneuron subtypes known to directly innervate excitatory neurons. The results suggest that BDNF, acting through glutamatergic transmission, can modulate hippocampal output in part by controlling alpha7-nAChR levels. FAU - Massey, Kerri A AU - Massey KA AD - Neurobiology Section, Division of Biological Sciences, 0357, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0357, USA. kamassey@ucsd.edu FAU - Zago, Wagner M AU - Zago WM FAU - Berg, Darwin K AU - Berg DK LA - eng GR - R01 NS012601/NS/NINDS NIH HHS/United States GR - R01 NS035469/NS/NINDS NIH HHS/United States GR - NS12601/NS/NINDS NIH HHS/United States GR - NS35469/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20061009 PL - United States TA - Mol Cell Neurosci JT - Molecular and cellular neurosciences JID - 9100095 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Chrna7 protein, rat) RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (Receptors, Nicotinic) RN - 0 (alpha7 Nicotinic Acetylcholine Receptor) RN - 76326-31-3 (2-amino-5-phosphopentanoic acid) RN - EC 4.1.1.15 (Glutamate Decarboxylase) RN - HG18B9YRS7 (Valine) SB - IM MH - Analysis of Variance MH - Animals MH - Animals, Newborn MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Cells, Cultured MH - Drug Interactions MH - Excitatory Amino Acid Antagonists/pharmacology MH - Glutamate Decarboxylase/metabolism MH - Hippocampus/*cytology MH - Immunohistochemistry/methods MH - Interneurons/*drug effects MH - Protein Transport/drug effects MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Nicotinic/genetics/*metabolism MH - Time Factors MH - Up-Regulation/*drug effects MH - Valine/analogs & derivatives/pharmacology MH - alpha7 Nicotinic Acetylcholine Receptor PMC - PMC1826088 MID - NIHMS14826 EDAT- 2006/10/13 09:00 MHDA- 2007/03/03 09:00 PMCR- 2008/02/01 CRDT- 2006/10/13 09:00 PHST- 2006/06/20 00:00 [received] PHST- 2006/08/04 00:00 [revised] PHST- 2006/08/30 00:00 [accepted] PHST- 2006/10/13 09:00 [pubmed] PHST- 2007/03/03 09:00 [medline] PHST- 2006/10/13 09:00 [entrez] PHST- 2008/02/01 00:00 [pmc-release] AID - S1044-7431(06)00192-8 [pii] AID - 10.1016/j.mcn.2006.08.011 [doi] PST - ppublish SO - Mol Cell Neurosci. 2006 Dec;33(4):381-8. doi: 10.1016/j.mcn.2006.08.011. Epub 2006 Oct 9.